SCHEMBL2086404

SCHEMBL2086404

NNc1ccncn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL29086472 0.95 HSP90AA1 (0.44)
SCHEMBL27986259 0.80
SCHEMBL4630887 0.79 GSK3A (0.53)
Hydrochloric Acid SCHEMBL7857018 0.77 GSK3A (0.51)
SCHEMBL30488472 0.75
SCHEMBL7854417 0.75
SCHEMBL29608372 0.75
SCHEMBL26698946 0.75
SCHEMBL311748 0.75
SCHEMBL27708097 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 203 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107652204-A A kind of epoxides grafting hydrazine reduction prepares and the method for dispersed graphite alkene 山东理工大学 2018-02-02 CN claimed
CN-103435555-B Preparation method of 4-chloro-5-methylpyrimidine WYLTON JINGLIN ELECTRONIC MATERIAL CO LTD 2015-06-24 CN claimed
CN-103435555-A Preparation method of 4-chloro-5-methylpyrimidine WYLTON JINGLIN ELECTRONIC MATERIAL CO LTD 2013-12-11 CN claimed
EP-4707276-A2 MALT1 MODULATORS AND USES THEREOF Rarefied Biosciences, Inc. (US) 2026-03-11 EP disclosed
US-20260062391-A1 HYDRAZIDE CONTAINING NUCLEAR TRANSPORT MODULATORS AND USES THEREOF KARYOPHARM THERAPEUTICS INC (US) 2026-03-05 US disclosed
EP-4499611-B1 MALT1 MODULATORS AND USES THEREOF RAREFIED BIOSCIENCES INC (US) 2026-02-18 EP disclosed
US-20250326738-A1 MALT1 Modulators and Uses Thereof RAREFIED BIOSCIENCES, INC. (US) 2025-10-23 US disclosed
US-12291508-B2 Hydrazide containing nuclear transport modulators and uses thereof Karyopharm Therapeutics Inc. (US) 2025-05-06 US disclosed
EP-4499611-A1 MALT1 MODULATORS AND USES THEREOF Rarefied Biosciences, Inc. (US) 2025-02-05 EP disclosed
CN-119032083-A MALT1 modulators and uses thereof 稀有生物科学股份有限公司 2024-11-26 CN disclosed
EP-4456900-A1 RESPIRATORY STIMULANT PARENTERAL FORMULATIONS Enalare Therapeutics Inc. (US) 2024-11-06 EP disclosed
US-4479955-A ANTICONVULSANTS, ANTIDEPRESSANTS, ANTIEPILEPTIC AGENTS CIBA-GEIGY CORPORATION (US) 1984-10-30 US disclosed
EP-0115469-A1 Pyrazolo(3,4-d)pyridin-3-ones condensed with a heterocycle CIBA-GEIGY AG (CH) 1984-08-08 EP disclosed
EP-0032131-B1 5-HALO-PYRIMIDIN-2-ONES, THE SALTS THEREOF, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM NYEGAARD &amp; CO. A/S (NO) 1983-09-21 EP disclosed
US-4399140-A CYTOTOXIC NYEGAARD & CO. A/S (NO) 1983-08-16 US disclosed
EP-0000383-B1 PYRIMIDO (4,5-C) PYRIDAZINES, THEIR USE IN PHARMACEUTICAL PREPARATIONS, AND PROCESS FOR THEIR PREPARATION THE WELLCOME FOUNDATION LIMITED (GB) 1982-10-13 EP disclosed
US-4328223-A 2-Amino-3a,4,5,6-tetrahydro-perimidine derivatives and their medicinal use in combatting circulatory diseases BAYER AKTIENGESELLSCHAFT (DE) 1982-05-04 US disclosed
EP-0032131-A1 5-Halo-pyrimidin-2-ones, the salts thereof, processes for their preparation and pharmaceutical compositions containing them NYEGAARD &amp; CO. A/S (NO) 1981-07-15 EP disclosed
US-4269980-A TRANQUILIZERS; ANTICONVULSANTS AMERICAN CYANAMID COMPANY (US) 1981-05-26 US disclosed
EP-0004904-A1 2-Amino-3a,4,5,6-tetrahydroperimidine derivatives, medicaments containing them and process for their preparation BAYER AG (DE) 1979-10-31 EP disclosed